Study of Respiratory Depression When Using a Hydromorphone Pain Protocol
Does a 1 Plus 1 Hydromorphone Pain Protocol Have a Similar Rate of Respiratory Depression to Physician Discretion Protocol in a Geriatric Population With Moderate to Severe Pain?
Sponsor: Albert Einstein Healthcare Network
Terminated
difficulty in recruiting
Other terminated trials from Albert Einstein Healthcare Network
- Post Prostatectomy · Jul 2022
- Abscess · Phase NA · Apr 2021
- Type 2 Diabetes Mellitus · Phase NA · Dec 2020
- COPD Exacerbation · Phase NA · Apr 2020
- Chronic Obstructive Pulmonary Disease · Phase NA · Oct 2018
See all terminations from Albert Einstein Healthcare Network
This NA trial investigates Pain and Respiratory Depression and is currently terminated or withdrawn. Albert Einstein Healthcare Network leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Dec 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 4 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Apr 2020 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Apr 2020 [monthly]
Terminated NA
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Albert Einstein Healthcare Network
For direct contact, visit the study record on ClinicalTrials.gov .